Robert Duggan Overview

  • Investor Type
  • Angel

  • Investments
  • 4

  • Portfolio
  • 3

  • Exits
  • 1

Exits

Robert Duggan General Information

Description

Mr. Robert Duggan is the Founder and serves as Chief Executive Officer at Duggan Investments. Mr. Duggan also serves as Chief Executive Officer at Summit. He served as the investor of Human Longevity. He served as a Board Member at OxStem. Mr. Duggan has been a member of the Board of Directors since September 2007 and was voted in as Chairman in September 2008 after the resignation of its former Chairman. He serves as a Board Member at Genoscience Pharma. Mr. Duggan has also served as Chairman of the Board of Directors of Computer Motion, Inc., a computerized surgical systems company, from 1990 to 2003 and as Chief Executive Officer from 1997. At that time, Mr. Duggan became a Board Member of Intuitive Surgical, Inc. and served on its board until March 2011. He has participated as a CEO of, a director of, an investor in, and an advisor to numerous small and large businesses in the medical equipment, computer, local and wide area network, PC hardware and software distribution, digital encryption, consumer retail goods, and outdoor media communication industries. Mr. Duggan has also assisted in corporate planning, capital formation, and management for his various investments. Mr. Duggan is a member of the University of California at Santa Barbara Foundation Board of Trustees. He is also an Angel Investor. His educational qualifications include a BS in Management and Operations from the University of California, Los Angeles (UCLA), and a degree in Economics from University of California, Santa Barbara.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • Clearwater, FL
  • United States

Robert Duggan Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Subskribe 17-Feb-2022 Early Stage VC Business/Productivity Software Generating Revenue
Human Longevity 04-Dec-2018 Biotechnology Generating Revenue
CASI Pharmaceuticals 21-Mar-2018 PIPE Drug Discovery Generating Revenue
Genoscience Pharma 01-Jan-2016 Later Stage VC Drug Discovery Clinical Trials - Phase 2

Robert Duggan Exits (1)

Company Name Exit Date Exit Type Exit Size
CASI Pharmaceuticals

Robert Duggan Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Robert Duggan Co-Investors (31)

Name With Exits Lead Partner Series Industry
515 Ventures 1 Series chart Industry bar
8VC Series chart Industry bar
Keenan Rice Series chart Industry bar
Louis Beryl Series chart Industry bar
Streamlined Ventures Series chart Industry bar

Robert Duggan FAQs

  • Who is Robert Duggan?

    Robert Duggan is an angel Investor who has made 4 investments.

  • What kind of investor is Robert Duggan?

    Robert Duggan is an angel investor.

  • What does Robert Duggan do?

    As an angel investor, Robert Duggan invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Robert Duggan hold?

    Robert Duggan holds 2 board seats including Pulse Biosciences and Genoscience Pharma.

  • What has Robert Duggan invested in?

    Robert Duggan has made numerous investments in companies like Subskribe, Human Longevity, and CASI Pharmaceuticals within the Business/Productivity Software, Biotechnology, and Drug Discovery industries.

  • What has Robert Duggan invested in recently?

    Robert Duggan's latest investment was on 17-Feb-2022 in Subskribe, a company within the Business/Productivity Software industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »